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Abstract
PURPOSE: Angiogenesis in advanced breast cancers is
highly distorted and heterogeneous. Noninvasive imag-
ing that can monitor angiogenesis may be invaluable
initially for diagnosis and then for assessing tumor
response to treatment. By combining ultrasound (US)
and near-infrared (NIR) optical imaging, a reliable new
technique has emerged for localizing and characterizing
tumor angiogenesis within the breast. METHODS: This
new technique employs a commercial US transducer
coupled with an array of NIR optical fibers mounted on a
hand-held probe. The US image is used for lesion
localization and for guiding optical imaging reconstruc-
tion. Optical sensors are used for imaging tumor total
hemoglobin distribution, which is directly related to
tumor angiogenesis. RESULTS: Six large breast carci-
nomas were studied and microvessel density count
was then performed on tissue samples obtained from
these cancers. Two patients had locally advanced breast
cancers and received neoadjuvant chemotherapy for
3 months. In one patient, before chemotherapy, the total
hemoglobin distribution showed a high concentration at
the cancer periphery; the distribution was later confined
to the core area after 3 months of treatment. In another
patient, as treatment progressed, the maximum hemo-
globin concentration decreased from 255.3, to 147.5, to
76.9 Mmol/l with an associated reduction in spatial
extension. The other four patients had cancers of 2.0
to 3.0 cm in size and were imaged either at the time of
core biopsy or definitive surgery. The histologic micro-
vessel density counts from these tumor samples cor-
relate to hemoglobin distributions with a correlation
coefficient of 0.64 (P < .05). CONCLUSION: These initial
results suggest that this new imaging technique may
have great potential in imaging the heterogeneous
vascular distribution of larger breast cancers in vivo
and in monitoring treatment-related changes in angio-
genesis during chemotherapy.
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Introduction
Noninvasive functional imaging of breast cancer presents
a unique and worthwhile challenge. Optical tomography
using near-infrared (NIR) diffused light offers great potential
as a method for monitoring tumor hemoglobin distribution
[1–4], which is directly related to the vascular component
of tumors. Angiogenesis is a key process for tumor growth
and metastasis. The use of this NIR method also provides
direct insights into tumor metabolism and tumor hypoxia [5],
which are important indicators of response to therapy. These
functional parameters are potentially useful in the initial
diagnosis of tumors and the assessment of tumor response
to treatment in the neoadjuvant setting. Intense light scat-
tering using NIR in tissues makes lesion localization diffi-
cult. Thus, to date, optical tomography has been limited to
laboratory tests and feasibility studies [5–9]. In this report,
we further describe our experience using a novel combi-
nation of ultrasound (US) and NIR to overcome the scatter-
ing obstacle.
US imaging is frequently used as an adjunct tool to mam-
mography in differentiating cysts from solid lesions. US also
plays an important role in guiding interventional procedures
such as needle aspiration, core needle biopsy, and pre-
biopsy needle localization [10]. However, US features that
occur in solid breast masses are not reliable enough to
determine whether invasive evaluation is needed or nonin-
vasive follow-up is indicated [11]. The lack of specificity of
US has prompted radiologists to recommend biopsies on
most solid nodules, resulting in a 70% to 90% negative
biopsy rate [12].
By combining US and optical imaging, a reliable tech-
nique has emerged for localizing and characterizing lesions
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within the breast [13–16]. The technique is implemented
by simultaneously deploying optical sensors and a commer-
cial US transducer mounted on a hand-held probe, and
utilizing coregistered lesion structure information provided
by US to improve the inverse optical imaging reconstruction.
Results have shown that early-stage invasive breast cancers
may be separated from benign lesions by their significantly
higher total hemoglobin concentration [16].
The process of angiogenesis is complex, resulting in a
highly distorted and heterogeneous distribution of blood
vessels in advanced cancers [17]. This distorted distribution
is dependent on angiogenic factors [18] and related to the
incorporation of existing host blood vessels into tumors and
the creation of tumor microvessels. Blood flow through
these tumor vessels is heterogeneous. Some areas have
high flow; others have slower flow and develop necrosis
[19]. Tumors with relatively poor blood perfusion may not
receive adequate delivery of systemic therapy. This lack of
perfusion may be a factor in the poor response to chemo-
therapy in some patients [20].
Although pilot studies of imaging tumor hemoglobin dis-
tributions have been conducted with optical tomography, no
one has demonstrated heterogeneous hemoglobin distribu-
tions in advanced cancers. In this paper, we report the ability
of optical tomography to correctly image heterogeneous
hemoglobin distributions in large cancers by correlating
these imaging results with histologic microvessel density
counts. We also demonstrate the potential of optical tomo-
graphy for monitoring tumor vascular responses to neoadju-
vant chemotherapy.
Materials and Methods
A hand-held hybrid probe consists of a commercial US
transducer located in the center and our NIR source detector
fibers mounted in a housing, distributed at the periphery [16].
The technical aspects of the NIR imager have been de-
scribed in detail previously [14]. Briefly, the imager consists
of 12 pairs of dual-wavelength (780 and 830 nm) laser
diodes, which are used as light sources, and their outputs
are coupled to the probe through optical fibers. An additional
wavelength (660 nm) is added to the system, which allows
a reliable estimation of tumor oxygenation saturation. On
the receiving side, eight photomultiplier tubes (PMTs) were
used to detect diffusely scattered light from the tissue and
eight optical fibers were used to couple detected light to the
PMTs. The laser diodes’ outputs were amplitude-modulated
at 140 MHz and the detector outputs were demodulated to
20 kHz. The demodulated signals were further amplified
and bandpass-filtered at 20 kHz. A reference signal of
20 kHz was also generated by directly mixing the detected
radiofrequency (RF) signals with the RF signal generated
from the oscillator. The reference signal was necessary for
retrieving phase shifts. Eight detection signals and one
reference were sampled and acquired into a computer
simultaneously. The entire data acquisition took about
3 to 4 seconds, which was fast enough for acquiring data
from patients.
The details of our dual-mesh optical imaging reconstruc-
tion algorithm have been described in Zhu et al. [15]. Briefly,
the NIR reconstruction takes advantages of US localization
of lesions and segments the imaging volume into a finer
grid in lesion region L and a coarser grid in nonlesion back-
ground region B. In all images, a 0.5  0.5  0.5-cm imaging
grid was used for lesion and 1.5  1.5  1 cm was used
for background region. A modified Born approximation is
used to relate the scattered field Usd measured at each
source (s) and detector pair (d) to total absorption variations
at wavelength in each volume element of two regions
within the sample. The matrix form of image reconstruction
is given by:
½UsdM1 ¼ ½WL;WBMN ½ML;MBTN1 ð1Þ
where WL and WB are weight matrices for lesion and
background regions, respectively, and are calculated from
background absorption and reduced scattering measure-
ments acquired at the normal contralateral breast. ML and
MB are total absorption distribution changes of lesion and
background regions, respectively. The absorption distribu-
tion at each wavelength is obtained by dividing ML and MB
by different voxel sizes in lesion and background tissue
regions. With this dual-mesh scheme, the inversion is well
conditioned and the image reconstruction converges in a
few iterations.
Because the major chromophores are deoxygenated
(deoxyHb) and oxygenated (oxyHb) hemoglobin in the wave-
length range studied, we can estimate deoxyHb and oxyHb
concentrations at each imaging voxel by inverting the follow-
ing equations, voxel by voxel, as:
where k1a ðr VÞand k2a ðr VÞ are absorption coefficients obtained
at imaging voxel r V, where wavelengths k1 and k2 correspond
to 780 and 830 nm in our system, respectively. e are
extinction coefficients given in Cope [27]. The total he-
moglobin concentration totalHbðr VÞ ¼ deoxyHbðr VÞ þ oxyHb
ðr VÞ and oxygenation saturation Y% ¼ oxyHbðr VÞoxyHbðr VÞþdeoxyðr VÞ100%
can be calculated as:
totalHbðr VÞ ¼ 1
D
fek2HbO2  e
k2
Hbgk1a ðr VÞ
n
þfek1Hb  ek1HbO2gk2a ðr VÞ
n o
ð4Þ
a
k1(r V) eHbk1 ,eHbO2
k1 deoxyHb(r V)
=  (2)
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and
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
k2
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þ ek1Hb
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where D ¼ ek1Hbek2HbO2  e
k1
HbO2
ek2Hb. We have found that the best
two wavelengths for total hemoglobin calculation are 780
and 830 nm, and the best two wavelengths for oxygen
saturation calculation are 660 and 830 nm. These wave-
length pairs were used in computing total hemoglobin con-
centration and oxygen saturation distributions reported in
the Results section.
Because US resolution is less than 1 mm in depth for a
typical 7.5-MHz US transducer such as the one we used, the
boundaries between cancerous and normal tissue struc-
tures can be visualized well. However, spatial extensions
of larger cancers, in general, are not well resolved in US. In
addition, the NIR three-dimensional data are coregistered
with one of the two spatial dimensions and depth dimen-
sions of US. Another spatial dimension is estimated by
assuming symmetry of lesion. Furthermore, the optical
contrast may well extend beyond the tumor periphery due
to angiogenesis development. Therefore, a larger region of
interest (ROI), particularly in spatial dimensions than that
visualized by US, is used for finer grid lesion region in the
image reconstruction. The ROI used for each patient is listed
in Table 1.
Clinical studies were performed at the University of Con-
necticut Health Center (UCHC). The UCHC IRB committee
approved the human subject protocol. Written consents were
obtained from all patients. Patients with palpable and non-
palpable masses that were visible on clinical US and who
were scheduled for biopsy or neoadjuvant chemotherapy
were enrolled as research subjects. Six patients with tumors
ranging from 2.5 to 4 cm were studied. For each patient, US
images and optical measurements were acquired simulta-
neously at multiple locations including the lesion region, a
normal region of the same breast if the breast was large, and
a normal symmetric region of the contralateral breast. The
optical data acquired at normal region with the best linear
amplitude and phase profiles were used as reference for
calculating the scattered field caused by lesions. The total
hemoglobin concentration maps are quantified by measuring
the maximum value at each depth (layer) and the average
within 50% of the maximum value. Because the hand-held
probe can be easily rotated or translated, at least three
coregistered US and NIR data sets were acquired at the
lesion location, and the corresponding optical absorption
maps as well as the total hemoglobin concentration distribu-
tion were reconstructed using the coregistered US. The data
given in Table 1, column 5 (left column) are average values
obtained from at least three sets of NIR images.
To correlate the imaged hemoglobin distribution with
histology microvessel density, we have performed micro-
vessel density counts. Samples obtained at biopsy or defin-
itive surgery were used for counting. For each sample,
sections 3 to 5 mm thick were stained on an immunohisto-
chemistry slide staining system (DAKO autostainer) with
factor 8/86 mouse monoclonal antibody (antihuman von
Willebrand factor; DAKO Corp., Carpinteria, CA) at 1:100
dilution digested by proteinase K for 3 minutes by labeled
polymers (DAKO EnVision plus) using the immunoperoxi-
dase method. Histologic microvessel density count was
assessed by immunohistochemistry as initially proposed by
Table 1. Histologic Microvessel Density Counts and Total Hemoglobin Measurements.
Cases Biopsy Sample
Location
Mvd Per
10 Fields at 200
Surgical Sample
Location
Mvd Per
10 Fields at 200
Total Hb
(Maximum/Mean)
Size-Measured ROI for NIR
by US (cm) Imaging (cm)
Case 1 NA NA ANT 114 (75.9/54.0) 4  4  1.5; 8.4  8.4  1.9
Invasive ductal NA NA POST/INF 48 (39.5/26.6)
Case 2 ANT 61* ANT 52 (45.9/31.6) 3  3  2.0; 9  9  2.0
Invasive ductal POST 40* POST 29 (42.9/30.8)
Case 3 NA NA ANT 83 (146.4/106.0) 2.5  2.5  1.3; 8  8  1.6
Invasive and in situ ductal NA NA POST 124y (174.9/122.3)
NA NA POST/LAT 121
Case 4 NA NA ANT/LAT 60y (112.5/81.1) 3  3  1.5; 7  7  1.7
NA NA ANT/MED 88
Invasive and in situ ductal NA NA POST/INF 152 (88.4/65.8)
Case 5 NA NA ANT 111 (77.2/55.6) 4  4  2.0; 8  8  2.0
NA NA POST 68 (16.1/12.9)
Invasive ductal ANT(LIQ)+ 190 ANT(LIQ) 61
Case 6 NA NA ANT 86y (97/66.5) 2  2  1.0; 7  7  1.0
Invasive ductal NA NA POST 109
ANT, anterior; POST, posterior; LAT, lateral; MED, medial; INF, inferior.
Mvd per 10 fields at 200: total microvessels per 10 consecutive fields at 200 magnifications.
+LIQ, low inner quadrant.
*For case 2, NIR/US data are acquired at core biopsy; therefore, the microvessel density counts obtained at the time of core US were used in Figure 5.
yThe average is used in obtaining Figure 5.
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Weidner et al. [20]. The microvessel density counts were
performed in 10 consecutive fields with the use of an ocular
grid at 200 magnification. The first field chosen was a
hotspot (area of maximum vascular density either within
the infiltrating tumor mass or at the tumor–stromal interface).
Because the cancers were large, two to three separate
sample blocks were selected for microvessel counts as per
specimen orientation in the surgical pathology report. The
performer was blinded from the NIR imaging results.
The surgeon always orients the excised specimen with
sutures designating the resection margins. Tumor sampling
for histologic studies demonstrates the relationship of
the tumor to the designated resection margins. Because the
patients were imaged from the anterior approach with the
patient in supine position, orientation of the anterior and deep
(posterior) locations within the optical and US images could
be easily linked to the orientation of the surgical material.
The linear regression curve of microvessel density count
versus measured maximum total hemoglobin concentration
at the corresponding location was obtained from least
square solutions. The correlation coefficient that reflecting
the goodness of fit was computed as: r ¼ coeffxyﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃvarxvaryp , where
coeffxy ¼
Xn
i¼1
ðxi  x¯Þðyi  y¯Þ; varx ¼
Xn
i¼1
ðxi  x¯Þ2; and
vary ¼
Xn
i¼1
ðyi  y¯Þ2  ðxiyi Þ is a sample point of microvessel
density count and its corresponding maximum total hemo-
globin concentration, and ðx¯ ; y¯Þ is the mean value of the
corresponding variables. The statistical significance was
tested on correlation coefficients with a confidence level
of 0.05.
Results
The first patient had a 4  4  1.5-cm palpable mass (Fig-
ure 1a) that was considered as highly suspicious for malig-
nancy. An US-guided needle biopsy confirmed that the lesion
was a poorly differentiated invasive ductal carcinoma with
necrosis. The total hemoglobin concentration map shown in
Figure 1b reveals that the distribution is highly heteroge-
neous. The image reveals a high concentration of hemo-
globin distributed at the cancer periphery. The maximum and
average hemoglobin concentrations of three layers (slices
3–5) are 90.7/56.2, 50.2/31.6, and 27.4/25.2 mmol/l, respec-
tively. Because this cancer was considered too large for
breast-conserving surgery with an acceptable cosmetic re-
sult, the patient was treated with chemotherapy in the neo-
adjuvant setting for 3 months. At the completion of her
chemotherapy, we imaged the tumor again. Figure 1c is
the US image of the cancer 3 months later. The cancer con-
trast is poor and cancer boundaries are completely unclear,
probably due to treatment. Figure 1d is the total hemoglobin
distribution. The maximum and average hemoglobin con-
centrations of the three layers (slices 3–5) are 73.6/52.5,
64.2/43.9, and 44.0/28.7 mmol/l, respectively. Compared with
the images acquired before treatment, the spatial extension
of the hemoglobin concentration is much smaller and more
confined to the core area. The maximum total hemoglobin
concentration is reduced by about 15 mmol/l.
To correlate the NIR images with microvessel densities,
we selected two block samples obtained at breast conser-
vation surgery marked as anterior and posterior (Figure 1c
insertion) for microvessel counting. The total numbers of
microvessels were 114 (anterior) and 48 (posterior and
inferior) per 10 consecutive fields at 200 magnification,
respectively (Table 1, case 1). The high counts obtained at
the anterior correlate with the high hemoglobin concentration
shown in slice 3 of Figure 1d. A representative section
demonstrating high microvessel density is shown in Figure
1e. The low counts obtained at posterior and inferior block
samples correlate with the low hemoglobin concentration
seen in the deeper slice 5 of Figure 1d.
The second patient had a 3  3  2-cm dominant mass.
US showed a hypoechoic mass with irregular margins (Fig-
ure 2a) and the lesion was considered as highly suspicious
for malignancy. Resection of the mass revealed a moder-
ately differentiated infiltrating carcinoma with low mitotic
activity. Figure 2b shows the total hemoglobin map; the
hemoglobin concentration is low and the distribution is
heterogeneous. The measured maximum total hemoglobin
concentration and average of three layers (slices 4–6) are
48.0/33.7, 48.4 /33.9, and 44.4/31.8 mmol/l, respectively. The
total counts of microvessels obtained from anterior and
posterior core biopsy samples were 61 and 40, respectively
(Table 1, case 2 ). The total counts measured from anterior
and posterior tumor samples obtained at definitive surgery
were 52 and 29, respectively. These low counts correlate well
with the low hemoglobin concentration shown in Figure 2b
and indicate that the tumor had a minimal vascular supply. A
representative section demonstrating low microvessel den-
sity is shown in Figure 2c.
The third example was obtained from a patient with a
diffusely swollen breast. No discrete mass was palpable. An
incisional biopsy from the lower inner quadrant showed a
poorly differentiated infiltrating ductal carcinoma. Positive
emission tomography (PET) imaging obtained before che-
motherapy treatment (Figure 3a) revealed a diffusely in-
volved breast with nodal and epidural metastasis. We
identified an upper quadrant mass from US and monitored
total hemoglobin concentration and oxygen saturation during
her neoadjuvant chemotherapy. Figure 4, a–c presents a US
image acquired at the beginning, after four and eight cycles
of chemotherapy; Figure 4, d– f are corresponding total
hemoglobin changes, and Figure 4, g– i are corresponding
oxygen saturation maps. The maximum hemoglobin concen-
tration had significantly decreased from 255.3 to 147.5 to
76.9 mol/l as did the spatial extension from the beginning to
the end of the treatment. High oxygen saturation was noted
in the tumor initially near the chest wall region (slices 6 and 7,
Figure 4g ) and fell to deoxygenated levels at the time of the
second scan (Figure 4, h and i ). The initial incisional biopsy
was in a region where there was no demonstrable mass on
US so the initial microvessel count is not from the same
region imaged by optical tomography shown in Figure 4d.
Microvessel counts of surgical samples obtained from
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anterior and posterior regions of the imaged area were 111
and 68, which correlate with higher and lower hemoglobin
images seen in slices 4 and 6 of Figure 4f. PET imaging
showed a complete response to chemotherapy (Figure 3b).
On completion of neoadjuvant chemotherapy, the patient
underwent left modified radical mastectomy. Residual tumor
was noted to be diffusely infiltrating all the quadrants of the
breast as well as beneath the nipple. However, there was
Figure 1. (a) US image of a 4  4-cm high-grade invasive ductal cancer. (b) Total hemoglobin concentration of the lesion. Slice 1 is an xy image of 9  9 cm
obtained at 0.2 cm depth from the skin surface, and slice 7 is 3.2 cm deep toward the chest wall. The order of slices is from left to right and from top to bottom. The
spacing between the slices is 0.5 cm. The vertical scale (mol/l) ranges from 0 to 100 mol/l. (c) US image of the same cancer treated with chemotherapy for
3 months. (d) Total hemoglobin concentration of the lesion and the vertical scale (mol/l) ranging from 0 to 100 mol/l. (e) Representative section of the infiltrating
ductal carcinoma of the breast demonstrating high microvessel density (original magnification, 200; anti –human von Willebrand factor, DAKO EnVision plus).
Figure 2. (a) US image of an intermediate-grade infiltrating ductal cancer. (b) Total hemoglobin concentration of the lesion (mol/l) ranging from 0 to 100 mol/l.
Slice 1 is an xy image of 9  9 cm obtained at 0.5 cm depth from the skin surface, and slice 7 is 3.5 cm deep toward the chest wall. (c) Representative section
of infiltrating ductal carcinoma of the breast demonstrating low microvessel density (original magnification, 200; anti –human von Willebrand factor; DAKO
EnVision plus).
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marked reduction in tumor cellularity to 5% throughout the
fibrotic bed of the residual tumor.
Table 1 summarizes the results of six cases. The histol-
ogy is given in column 1. Columns 2 and 3 list the location of
core biopsy samples and the corresponding microvessel
counts. Four cases were diagnosed with fine needle biopsy
and no tumor sample was available for microvessel density
counting. Columns 4 and 5 (left) provide the location of the
surgical sample obtained at definitive surgery and the cor-
responding microvessel counts. The maximum and average
hemoglobin concentrations at the corresponding depth
(layer) were given in column 5 (right). The US-measured
cancer size (right) at the time of the study, or at the beginning
of the chemotherapy, and the ROI used for finer mesh (left)
for each case are given in the last column. The data of
microvessel density count (column 5, left) versus measured
maximum total hemoglobin concentration (column 5, right)
are shown in Figure 5. The linear regression curve is also
given in the figure and the correlation coefficient is 0.64,
which is statistically significant (P < .05). One data point ob-
tained at the posterior/inferior location of case 4 was an out-
lier and was removed to obtain the linear regression curve.
Discussion
Optical tomography with US localization appears to have
potential value in distinguishing benign from smaller malig-
nant tumors [16]. The current study elucidates additional
benefits when studying larger tumors (to map tumor vascu-
larity and tumor hypoxia). These indices can be followed
before and during therapeutic interventions. It has been
shown that tumor hypoxia is related to the growth rate and
chemotherapeutic responsiveness of tumors [28]. The ability
to demonstrate and follow these parameters before and
during therapy noninvasively could prove invaluable in
choosing tailored treatments especially in the era of new
drugs targeting angiogenesis.
Some of the other newer imaging techniques do not have
this capability. These techniques utilized clinically and ex-
perimentally include 15O–water contrast-enhanced positron
emission tomography [21], dynamic contrast-enhancedmag-
netic resonance imaging (MRI) [22,23], 99m Tc-sestamibi
contrast-enhanced single-photon emission tomography
[24,25], and Doppler sonography [26]. The first three tech-
niques require rather expensive systems and may only be
used at the beginning and end of chemotherapy, leaving the
entire treatment period completely unmonitored. The Dopp-
ler sonography is limited to imaging large blood vessels.
Compared with Doppler sonography, which visualizes larger
blood vessels, optical tomography images tumor microves-
sel density, which is directly related to tumor angiogenesis
distributions. Furthermore, NIR systems are cost-effective,
portable, and easily coupled to clinical US systems for
repeated imaging.
Although pilot studies of imaging tumor hemoglobin dis-
tributions have been conducted with optical tomography, no
one has obtained heterogeneous hemoglobin distributions in
advanced cancers and demonstrated its correlation with his-
tologic microvessel density counts. In this paper, we report
the first heterogeneous hemoglobin distributions of large
cancers imaged by optical tomography, and we show that
the hemoglobin distribution correlates to histologic micro-
vessel density counts. We also demonstrate the potential of
optical tomography to monitor the response of tumors, more
specifically their vascularity, to neoadjuvant chemotherapy.
For each individual patient, except case 4, the maximum
and average total hemoglobin concentrations measured at
the top and bottom layers correlate to the histologic micro-
vessel density counts obtained at anterior and posterior
samples, respectively. The NIR data from case 4 were
Figure 3. PET images of a patient who presented with a diffusely swollen breast. Core biopsy revealed a high-grade infiltrating ductal cancer. (a) Image acquired
before chemotherapy. The small black arrow indicates the diffuse involvement of the breast. The longer black arrow indicates positive lymph nodes (black dots).
The white arrow displays an area of metastatic disease (epidural). (b) PET image acquired after eight cycles of chemotherapy, before definitive surgery. No
evidence of disease remains.
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different from the others because the imaging was done
8 days after the biopsy at the time of the patient visit.
Postbiopsy wound healing may impact on vascularity mea-
sured by NIR. NIR scans of other patients were done prior
to any invasive procedures (cases 1–3 and 5) or 3 months
later after initial fine needle biopsy (case 6). In addition, this
patient was completing her first trimester pregnancy at the
time of the study. The larger variation in total counts at dif-
ferent tumor locations may partially relate to the inherent
heterogeneity of breast tissues and tumors, and the differ-
ential distribution of angiogenesis in the viable and schirrous
regions. Nevertheless, the relatively higher counts obtained
from the three sample blocks correlate to a large extent to the
high hemoglobin distribution.
In the reported studies, we have used bulk absorption and
reduced scattering coefficients obtained from the fitting
results of normal breasts to compute the weight matrices.
We reconstructed the absorption variations of both lesion
and background, and then computed the total hemoglobin
distribution from the absorption changes. Optical scattering
changes also contribute to the measured perturbations. We
have attempted to reconstruct both absorption and reduced
scattering changes simultaneously, but have not been suc-
cessful with the modified Born approximation. The main
reason is that the weight matrices of absorption and scatter-
ing coefficients are not on the same order. By appropriately
scaling the weight matrices as reported in Huang et al. [29],
we can improve the simultaneous reconstruction for phan-
tom targets but not reliably for all clinical cases. Currently, we
are investigating simultaneous reconstruction using the finite
element method. We are also investigating the time-resolved
method [30] because scattering inhomogeneities mainly
influence photons with rather short propagation paths
[31,32]. However, a study of 13 optically visible cancers
using the time-resolved method has shown that 12 cases
have presented 10% to 175% relative changes in absorption
between tumors and surrounding tissues [8]. Only two cases
have shown relative scattering heterogeneity changes from
10% to 15%, and one case has shown changes of 25% from
the bulk value. Therefore, we believe that the results
reported here mainly represent the changes of lesion ab-
sorption, and the correlation between the total hemoglobin
Figure 4. Corresponding US images acquired at the beginning (a), after four cycles (b), and after eight cycles (c) of chemotherapy. (d– f) Corresponding NIR
hemoglobin concentrations. (g– i) Oxygen saturation maps. Slice 1 is an xy image of 9  9 cm obtained at 0.5 cm depth from the skin surface, and slice 7 is 3.5
cm deep toward the chest wall. The slices in (d) – (I) are numbered from left to right and from top to bottom.
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concentration and the microvessel counts provides further
evidence of this.
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